VEGFA and Alzheimer disease: Nonpreconditioned and EPA-preconditioned AD-MSCs reduced protein levels of inflammatory and fibrotic biomarkers in lung tissues, but EPA-preconditioned AD-MSCs further reduced IL-1β and KC as well as increased VEGF levels